Biogen Inc (NASDAQ:BIIB)

284.41
Delayed Data
As of May 24
 +0.66 / +0.23%
Today’s Change
244.28
Today|||52-Week Range
370.57
-10.72%
Year-to-Date

Stock Price Forecast

The 28 analysts offering 12-month price forecasts for Biogen Inc have a median target of 358.50, with a high estimate of 425.00 and a low estimate of 272.00. The median estimate represents a +26.05% increase from the last price of 284.41.

Analyst Recommendations

The current consensus among 32 polled investment analysts is to Buy stock in Biogen Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$5.32
Sales
$3.2B
Reporting Date
Jul 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.08%
 
 
 
 
 
 
Growthannually 9.21%
 
 
 
 
 
 

Sales

Growthquarterly 3.45%
 
 
 
 
 
 
Growthannually 5.56%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.